Employees: 6,885
Size Kovai Medical Center & Hospital (KOVAI.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $759M, the 705th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹6,490 on 18 Nov 2026.
Performance Over six months the shares gained 21.5%, against +2.2% for the median peer and +3.8% for the India market (cap-weighted) — 5th highest of 20 in its peer set.
Growth Revenue grew 16.7% over the last twelve months (peer median +11.9%); the operating margin is 21.2% (peer median 10.8%).
Valuation It trades at 4.1× enterprise value to sales against a peer median of 2.9× (9th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -1 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 7.1 points above its cost of capital (11.5% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹17.2B | ₹15.8B | ₹13.7B | ₹12.2B | ₹10.2B |
| Revenue growth | — | +16% | +12% | +20% | — |
| Gross profit | ₹5.59B | ₹4.08B | ₹3.54B | ₹3.15B | ₹3.86B |
| EBITDA | ₹4.88B | ₹4.48B | ₹3.93B | ₹3.47B | ₹2.75B |
| Net income | ₹2.71B | ₹2.44B | ₹2.09B | ₹1.80B | ₹1.16B |
| Free cash flow | n/a | ₹1.02B | -₹294M | ₹1.77B | ₹990M |
| Capital expenditure | n/a | ₹2.52B | ₹3.53B | ₹1.38B | ₹1.27B |
| Total debt | ₹3.77B | ₹4.03B | ₹4.15B | ₹3.10B | ₹5.11B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | KOVAI.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +10.5% | +1.2% | 5th highest of 20 |
| 6-month return | +21.5% | +2.2% | 5th highest of 20 |
| Distance from 52-week high | -3.8% | -12.9% | 4th highest of 21 |
| Revenue growth (TTM) | +16.7% | +11.9% | 7th highest of 21 |
| Operating margin | 21.2% | 10.8% | 3rd highest of 21 |
| EV / Sales | 4.1× | 2.9× | 9th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 17.4% | 11.4% | 6th most demanding of 15 |
| Growth delivered (Del g) | +18.1% | +12.0% | 6th highest of 15 |
| Hurdle (Req g minus delivered) | -0.8 pp | -0.6 pp | 8th least demanding of 15 |
| ROIC minus cost of capital | +7.1 pp | -2.2 pp | 4th highest of 21 |
| EV / EBITDA | 14.6× | 16.3× | 9th cheapest of 17 |
| Net debt / EBITDA | 0.0× | 1.0× | 4th least indebted of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Kovai Medical Center & Hospital KOVAI.NS | India | $759M | +22% | +17% | 21% | 4.1× | 17.4% | +18.1% |
| Thomson Medical A50.SI | Singapore | $923M | -18% | +6% | 10% | 5.5× | 21.2% | +11.8% |
| HealthCare Global Enterprises HCG.NS | India | $955M | -7% | +13% | 8% | 3.9× | n/a | n/a |
| Paras Healthcare PARASHLTH.NS | India | $962M | n/a | +24% | 11% | 6.4× | n/a | n/a |
| Ramsay Generale de Sante GDS.PA | France | $969M | -25% | +3% | 4% | 0.9× | 6.1% | +6.0% |
| Artemis Medicare Services ARTEMISMED.NS | India | $582M | +25% | +15% | 13% | 4.8× | 48.5% | +21.5% |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 2.8× | 2.3% | +19.7% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 6.0× | n/a | n/a |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 0.6× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 5.8× | 22.1% | +10.2% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.13B | +31% | +50% | 16% | 7.2× | n/a | n/a |
| Garofalo Health Care GHC.MI | Italy | $508M | -3% | +4% | 10% | 1.4× | 1.7% | +18.3% |
| CVS CVSG.L | United Kingdom | $1.22B | +17% | +6% | 11% | 1.7× | 14.2% | +6.9% |
| Raffles Medical BSL.SI | Singapore | $1.23B | -13% | -3% | 11% | 1.8× | -2.7% | +6.1% |
| Spire Healthcare SPI.L | United Kingdom | $1.31B | +11% | +2% | 8% | 1.4× | 10.0% | +11.4% |
| Sanbo Hospital Management 301293.SZ | China | $1.35B | -29% | +17% | 6% | 4.9× | n/a | n/a |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.37B | -7% | +23% | 22% | 7.0× | 30.7% | +21.2% |
| Aevis Victoria AEVS.SW | Switzerland | $1.43B | +8% | +15% | -6% | 1.8× | 26.5% | +10.2% |
| Charm Care 6062.T | Japan | $402M | +57% | +6% | 11% | 1.2× | -0.4% | +16.4% |
| Xi'an International Medical Investment 000516.SZ | China | $1.46B | -2% | -1% | -2% | 3.1× | 12.7% | +20.6% |
| Voxel VOX.WA | Poland | $393M | +59% | +14% | 24% | 2.7× | 1.2% | +12.2% |